AssetMark Inc
FBT icon

AssetMark Inc’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

AssetMark Inc’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.14M Sell
22,567
-1,873
-8% -$487K 0.01% 688
2026
Q2 		$6.06M Sell
24,440
-30,777
-56% -$6.63M 0.01% 686
2026
Q1 		$11.1M Buy
55,217
+8,657
+19% +$1.79M 0.02% 474
2025
Q4 		$9.6M Buy
46,560
+6,017
+15% +$1.2M 0.02% 506
2025
Q3 		$7.27M Buy
40,543
+2,452
+6% +$418K 0.02% 542
2025
Q2 		$6.15M Buy
38,091
+8,670
+29% +$1.38M 0.01% 532
2025
Q1 		$5M Buy
29,421
+1,281
+5% +$222K 0.01% 511
2024
Q4 		$4.68M Sell
28,140
-312
-1% -$53.3K 0.01% 522
2024
Q3 		$4.89M Buy
28,452
+19,978
+236% +$3.31M 0.01% 454
2024
Q2 		$1.3M Buy
8,474
+967
+13% +$145K ﹤0.01% 710
2024
Q1 		$1.15M Buy
7,507
+1,513
+25% +$231K ﹤0.01% 692
2023
Q4 		$947K Buy
5,994
+3,733
+165% +$536K ﹤0.01% 691
2023
Q3 		$331K Buy
+2,261
New +$345K ﹤0.01% 805
2022
Q1 		– Sell
-514
Closed -$83K – 1613
2021
Q4 		$83K Buy
+514
New +$83.1K ﹤0.01% 821
2020
Q4 		– Sell
-4,210
Closed -$662K – 1414
2020
Q3 		$662K Buy
4,210
+2,217
+111% +$362K ﹤0.01% 376
2020
Q2 		$334K Buy
1,993
+468
+31% +$73.5K ﹤0.01% 439
2020
Q1 		$200K Buy
1,525
+705
+86% +$100K ﹤0.01% 492
2019
Q4 		$122K Sell
820
-45
-5% -$6.18K ﹤0.01% 602
2019
Q3 		$107K Buy
865
+511
+144% +$68K ﹤0.01% 600
2019
Q2 		$50K Buy
354
+255
+258% +$35.2K ﹤0.01% 696
2019
Q1 		$15K Buy
+99
New +$14.2K ﹤0.01% 930

Other funds holding FBT

Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
D.A. Davidson & Co
D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Hartford Financial Management
Hartford Financial Management Hartford, Connecticut $448M AUM 24.02% 1-Year Est. Return
Arlington Financial Advisors
Arlington Financial Advisors Santa Barbara, California $796M AUM 16.35% 1-Year Est. Return
B. Riley Wealth Advisors
B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
SFI Advisors
SFI Advisors Montclair, New Jersey $122M AUM 28.71% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

AssetMark Inc's FBT Position: Q3 2026 in Review

AssetMark Inc reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 7.7% in Q3 2026, selling an estimated $487K and leaving 22,567 shares worth $6.14M. The position accounts for 0.01% of the portfolio, ranked #688.

AssetMark Inc first reported a position in FBT in Q1 2019 and has held it in 21 quarters since. The position peaked at $11.1M in Q1 2026. 134 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • AssetMark Inc held 22,567 shares of First Trust NYSE Arca Biotechnology Index Fund worth $6.14M as of Q3 2026.
  • AssetMark Inc sold 1,873 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $487K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of AssetMark Inc's portfolio in Q3 2026, its #688 holding.
  • AssetMark Inc first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and has held it in 21 quarters since.
  • AssetMark Inc's First Trust NYSE Arca Biotechnology Index Fund position peaked at $11.1M in Q1 2026.
  • 134 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.